When should dialysis be started for hyperammonemia, including specific plasma ammonia thresholds and clinical signs, and which dialysis modality is preferred?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dialysis Recommendations for Hyperammonemia

When to Initiate Dialysis

Kidney replacement therapy (KRT) should be initiated urgently when ammonia levels exceed 150 μmol/L (255 μg/dL) in the presence of rapidly deteriorating neurological status, coma, or cerebral edema. 1, 2

Specific Ammonia Thresholds for Dialysis Initiation

  • Ammonia >150 μmol/L with neurological deterioration: Immediate CKRT is indicated when patients develop moderate to severe encephalopathy (lethargy, distal flexion, reduced activity, hypotonia, weak suck, constricted pupils, bradycardia) or severe encephalopathy (stupor, coma, absent activity, decerebrate posture, flaccid tone, absent reflexes, non-reactive pupils). 2

  • Ammonia 301-499 μmol/L (513-850 μg/dL): Initiate nitrogen-scavenging agents immediately while preparing for dialysis if moderate to severe encephalopathy or seizures are present. 1

  • Ammonia >300-400 μmol/L despite medical management: Consider CKRT when levels remain persistently elevated despite nitrogen-scavenging therapy. 1, 2, 3

  • Ammonia >400 μmol/L: Do not delay dialysis while waiting for medical management alone, especially with neurological symptoms. 4

  • Ammonia ≥600 μg/dL (360 μmol/L): Hemodialysis is indicated to rapidly remove ammonia and mitigate brain damage at this threshold. 5

Clinical Decision Algorithm

The decision to initiate KRT should be based primarily on clinical status rather than rigid ammonia thresholds alone. 2 Key clinical indicators include:

  • Presence of encephalopathy (any grade)
  • Seizure activity with consistent EEG findings
  • Rapid rise in ammonia levels within hours
  • Failure to respond to nitrogen-scavenging agents after 2 hours 1

Important caveat: If ammonia levels fail to fall below 150 μmol/L or by more than 40% within 4-8 hours after receiving nitrogen-scavenging therapy, hemodialysis is recommended. 6

Preferred Dialysis Modality

High-dose continuous venovenous hemodialysis (CVVHD) is the first-line preferred modality for severe hyperammonemia when available. 2, 3

CVVHD Technical Parameters

  • Blood flow rate (Qb): 30-50 mL/min 2, 3
  • Dialysate flow rate (Qd): Aim for Qd/Qb ratio >1.5 2, 3
  • Dialysate temperature: Use warmed dialysate to maintain hemodynamic stability 2, 3
  • Duration: Continue until ammonia <200 μmol/L on two consecutive hourly measurements 2, 3

Comparative Efficacy of Dialysis Modalities

CVVHD provides superior ammonia clearance compared to other modalities while preserving hemodynamic stability and minimizing rebound hyperammonemia. 2 The clearance rates differ significantly:

  • Intermittent hemodialysis (HD): Achieves 50% reduction in ammonia within 1-2 hours, with clearance of 3.95-5.37 mL/min/kg and filtration fraction of 95-96%. 1, 2

  • CVVHD: Achieves 50% reduction within 2-14 hours, with clearance of 2.65-6.80 mL/min/kg and filtration fraction of 53-58%. 1

  • Continuous arteriovenous hemodialysis (CAVHD): Lower clearance of 0.87-0.97 mL/min/kg with filtration fraction of 12.5-14.3%. 1

Alternative and Hybrid Approaches

Intermittent hemodialysis followed by CKRT (hybrid/sequential therapy) is recommended when rapid ammonia clearance is needed, particularly in hemodynamically unstable neonates. 2, 3 This approach:

  • Achieves rapid initial reduction (75% decrease within 3-4 hours) 3
  • Prevents rebound hyperammonemia through subsequent CKRT 2
  • Maintains hemodynamic stability in critically ill patients 2

Peritoneal dialysis is not recommended as first-line therapy due to inferior ammonia clearance compared to CVVHD and HD. 1

Treatment Goals

  • Target ammonia post-KRT: <200 μmol/L (280.1 μg/dL) 1
  • Monitoring frequency: Check plasma ammonia every 3-4 hours until normalized 2, 3
  • Neurological assessment: Regular evaluation for signs of encephalopathy, cerebral edema (pupillary changes, posturing, bradycardia) 2

Critical Prognostic Factor

The duration of hyperammonemic coma prior to dialysis initiation is the most important prognostic factor for neurological outcome, not the rate of ammonia clearance. 2 This underscores the importance of early recognition and immediate treatment initiation. Despite effective ammonia clearance with dialysis, mortality remains high (25%) in neonatal-onset cases, with only 20% achieving normal outcomes. 7

Common Pitfalls and Caveats

  • Sample collection errors: Ammonia samples must be collected from free-flowing venous or arterial blood, transported on ice, and processed within 15 minutes to avoid false elevations. 2, 3, 4

  • Delayed dialysis initiation: Waiting for medical management alone at levels >400 μmol/L with neurological symptoms increases risk of irreversible brain damage. 4

  • Nitrogen scavenger clearance: Nitrogen-scavenging agents will be dialyzed during CKRT but remain effective when used concurrently. 3

  • Prolonged protein restriction: Do not extend protein restriction beyond 48 hours, as this causes catabolism and worsens ammonia levels; reintroduce protein gradually (0.25 g/kg daily increments) when ammonia trends toward 80-100 μmol/L. 2, 4

  • Inappropriate use of lactulose: Do not use lactulose for urea cycle disorders or non-hepatic hyperammonemia, as it is ineffective and delays definitive treatment. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Asymptomatic Hyperammonemia (≈ 90 µmol/L)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hyperammonemia in urea cycle disorders: A toxic metabolite for the brain.

Pediatrics international : official journal of the Japan Pediatric Society, 2025

Related Questions

What is the next step in managing a 2-day-old boy with suspected urea cycle disorder, presenting with poor feeding, vomiting, decreased consciousness, intermittent apnea, normal glucose levels, and markedly elevated ammonia levels?
What is the next step in managing a 2-day-old boy with suspected urea cycle disorder, presenting with poor feeding, vomiting, decreased consciousness, intermittent apnea, normal glucose, and markedly elevated ammonia levels?
What is the next step in managing a neonate with suspected urea cycle disorder and severe hyperammonemia?
What is the next step in managing a 2-day-old boy with suspected urea cycle disorder, presenting with poor feeding, vomiting, decreased consciousness, intermittent apnea, normal glucose levels, and markedly elevated ammonia levels (hyperammonemia)?
Is ammonia dialyzable?
In an adult with symptomatic chronic venous insufficiency, can Daflon (diosmin + hesperidin) be used, and what is the recommended dose and duration?
What is the recommended prophylactic dose of Clexane (enoxaparin) for deep‑vein thrombosis in adults based on body weight and renal function?
What are the indications for low‑molecular‑weight heparins and how should they be administered, including dosing and necessary adjustments?
As a male on an SSRI with high total testosterone but low libido, should I ask my provider to order sex hormone‑binding globulin (SHBG) and free testosterone levels and evaluate reversible causes of elevated SHBG?
What is the normal pulmonary artery pressure at rest?
In a patient with end‑stage renal disease on dialysis whose calciphylaxis ulcer has healed, should sodium thiosulfate be continued continuously?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.